Skip to main content
Premium Trial:

Request an Annual Quote

GeneProt Names CFO, CTO, and Head of IP

NEW YORK, August 17 – GeneProt has appointed Bertrand Damour chief financial officer, Stephen Macevicz, vice president of intellectual property, and Diana Wetmore chief technical officer for the Geneva branch, the company announced on Friday.

Bertrand Damour joins the proteomics company from JP Morgan in London, where he was senior vice president and co-head of the investment banking risk management group. Prior to that, Damour worked at Deutsche Bank and Bankers Trust.

Stephen Macevicz was formerly vice president of legal affairs at Lynx Therapeutics. Prior to that, Macevicz was senior patent attorney and chief patent counsel at Applied Biosystems.

Diana Wetmore served at Anadys Pharmaceuticals, formerly Scriptgen Pharmaceuticals, as senior director of R&D project management. She also worked at DuPont Merck Pharmaceutical researching biophysical characterization of protein-ligand interactions.

GeneProt is based in Evanston, Ill.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.